InsidersTradesSigma
인바이오: directors' dealings · South Korea · DART (FSS)
DART:company-22354bKR·DART (FSS)Mcap 24.5Bn€Basic Materials
Explore the full directors' dealings record of 인바이오, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Basic Materials sector, 인바이오 has published 3 public disclosures. Market capitalisation: €24.5bn. The latest transaction was reported on 30 March 2026 — Purchase. Among the most active insiders: 이혁재. The full history is free.
3
Insider Decl.
0
Thresholds
€5,940
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2250.00 €
Analyst consensus
Income statement
Revenue33.95 Bn€
Gross profit11.81 Bn€35% margin
Net income1.01 Bn€3.0% margin
Valuation
Beta0.68
Balance sheet & cash
Market cap24.45 Bn€
Total debt14.06 Bn€
Free Cash Flow2.01 Bn€
Debt / Equity33%
Profitability & ownership
ROE2.4%
ROA0.8%
% insiders43.7%
% institutions0.0%
Last declaration on 30 March 2026
Declarations3 total
3 of 3 declarations